Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Unipol beats 3-year profit goal in 2025; shares jump 5% (Investing.com) +++ UNIPOL Aktie +4,97%

TANDEM DIABETES Aktie

 >TANDEM DIABETES Aktienkurs 
16.263 EUR    (TradegateBSX)
Ask: 16.51 EUR / 160 Stück
Bid: 16.015 EUR / 160 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>TANDEM DIABETES Performance
1 Woche: -1,2%
1 Monat: -10,1%
3 Monate: -5,7%
6 Monate: +65,9%
1 Jahr: -51,1%
laufendes Jahr: -18,1%
>TANDEM DIABETES Aktie
Name:  TANDEM DIABETES NEW -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US8753722037 / A2H5BX
Symbol/ Ticker:  TD5A (Frankfurt) / TNDM (NASDAQ)
Kürzel:  FRA:TD5A, ETR:TD5A, TD5A:GR, NASDAQ:TNDM
Index:  -
Webseite:  https://www.tandemdiabete..
Profil:  Tandem Diabetes Care Inc. is a medical device company specializing in the design and manufacturing of innovative insulin delivery systems. The company's primary focus is on products intended for diabe..
>Volltext..
Marktkapitalisierung:  1085.92 Mio. EUR
Unternehmenswert:  1197.02 Mio. EUR
Umsatz:  851.09 Mio. EUR
EBITDA:  -68.25 Mio. EUR
Nettogewinn:  -171.88 Mio. EUR
Gewinn je Aktie:  -2.58 EUR
Schulden:  379.72 Mio. EUR
Liquide Mittel:  77.71 Mio. EUR
Operativer Cashflow:  -7.43 Mio. EUR
Bargeldquote:  1.26
Umsatzwachstum:  11.84%
Gewinnwachstum:  -52.2%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  TANDEM DIABETES
Letzte Datenerhebung:  20.02.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 67.8 Mio. St.
Frei handelbar: 98.97%
Rückkaufquote: 0.23%
Mitarbeiter: 2650
Umsatz/Mitarb.: 0.3 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 35.75%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.33
KBV: 9.49
PEG-Ratio: -0.11
EV/EBITDA: -
Rentabilität:
Bruttomarge: 53.23%
Gewinnmarge: -20.2%
Operative Marge: -9.75%
Managementeffizenz:
Gesamtkaprendite: -22.2%
Eigenkaprendite: -109.73%
>Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Diabetes- & Adipositas- Behandlung
 
20.02.26 - 08:27
Tandem Diabetes Care targets 10-11% pump shipment growth in 2026 with PayGo transition (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.02.26 - 01:45
Tandem Diabetes Care (TNDM) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
 
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
20.02.26 - 01:00
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
 
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +80.51% and +5.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
19.02.26 - 23:33
Tandem Diabetes rises following Q4 earnings beats (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.02.26 - 22:27
Tandem Diabetes Care GAAP EPS of -$0.01 beats by $0.05, revenue of $290.4M beats by $13.16M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 19:18
Tandem Diabetes Care′s Earnings Outlook (Benzinga)
 
Importance Rank:  1 read more...
17.02.26 - 16:45
Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics (Zacks)
 
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Tandem Diabetes Care (TNDM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025....
07.02.26 - 12:33
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Feb. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
04.02.26 - 23:27
Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views (Benzinga)
 
Latest Ratings for TNDM DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022CitigroupMaintainsBuy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for TNDM View the Latest Analyst Ratings Importance Rank:  1 read more...
31.01.26 - 19:33
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Jan. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
27.01.26 - 02:06
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
22.01.26 - 02:33
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
17.01.26 - 03:03
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Jan. 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
08.01.26 - 22:09
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 (Business Wire)
 
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2025 financial and operating results. A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register-conf.media-server.com/register/BIcf3966da609740b59045972812b7b1ee) and you will be provided with dial-in details, including a personal pin. An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor....
31.12.25 - 01:09
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
26.12.25 - 00:27
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Dec. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
18.12.25 - 00:12
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
12.12.25 - 16:36
Don′t Buy Tandem Diabetes Care Until This Big Thing Happens (Fool)
 
The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism....
11.12.25 - 22:51
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
09.12.25 - 15:01
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
 
TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Man glaubt gar nicht, wie schwer es oft ist, eine Tat in einen Gedanken umzusetzen! - Karl Kraus
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!